Literature DB >> 28687340

Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases.

Gianna Huber1, Franziska Schuster1, Walter Raasch2.   

Abstract

Cardiovascular diseases (CVD) are among the main causes of death globally and in this context hypertension represents one of the key risk factors for developing a CVD. It is well established that the peripheral renin-angiotensin system (RAS) plays an important role in regulating blood pressure (BP). All components of the classic RAS can also be found in the brain but, in contrast to the peripheral RAS, how the endogenous RAS is involved in modulating cardiovascular effects in the brain is not fully understood yet. It is a complex system that may work differently in diverse areas of the brain and is linked to the peripheral system by the circumventricular organs (CVO), which do not have a blood brain barrier (BBB). In this review, we focus on the brain angiotensin peptides, their interactions with each other, and the consequences in the central nervous system (CNS) concerning cardiovascular control. Additionally, we present potential drug targets in the brain RAS for the treatment of hypertension.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiotensin (1–7); Angiotensin II; Angiotensin III; Brain renin-angiotensin system; Cardiovascular disease; Hypertension

Mesh:

Substances:

Year:  2017        PMID: 28687340     DOI: 10.1016/j.phrs.2017.06.016

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  20 in total

1.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 2.  The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Clin Auton Res       Date:  2018-11-09       Impact factor: 4.435

3.  Development of obesity can be prevented in rats by chronic icv infusions of AngII but less by Ang(1-7).

Authors:  Martina Winkler; Michael Bader; Franziska Schuster; Ines Stölting; Sonja Binder; Walter Raasch
Journal:  Pflugers Arch       Date:  2018-02-11       Impact factor: 3.657

Review 4.  Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Jeffrey L Osborn; Analia S Loria
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-23       Impact factor: 3.619

5.  Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina.

Authors:  Ping Zhu; Amrisha Verma; Tuhina Prasad; Qiuhong Li
Journal:  Mol Neurobiol       Date:  2019-08-07       Impact factor: 5.590

6.  The antiobese effect of AT1 receptor blockade is augmented in mice lacking Mas.

Authors:  Carla Dapper; Franziska Schuster; Ines Stölting; Florian Vogt; Lucas Araújo Castro E Souza; Natalia Alenina; Michael Bader; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-03-13       Impact factor: 3.000

7.  Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Authors:  Alynne Carvalho-Galvão; Blessing Ogunlade; Jiaxi Xu; Cristiane R A Silva-Alves; Leônidas G Mendes-Júnior; Drielle D Guimarães; Josiane C Cruz; Thyago M Queiroz; Camille M Balarini; Valdir A Braga; Catalin M Filipeanu; Eric Lazartigues; Maria do Socorro de França-Silva
Journal:  Clin Sci (Lond)       Date:  2018-07-23       Impact factor: 6.124

Review 8.  Integrative Physiological Aspects of Brain RAS in Hypertension.

Authors:  Sharon D B de Morais; Julia Shanks; Irving H Zucker
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

Review 9.  Potential mechanisms of hypothalamic renin-angiotensin system activation by leptin and DOCA-salt for the control of resting metabolism.

Authors:  Sarah A Sapouckey; Guorui Deng; Curt D Sigmund; Justin L Grobe
Journal:  Physiol Genomics       Date:  2017-10-06       Impact factor: 3.107

10.  Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior.

Authors:  Gianna Huber; Mikolaj Ogrodnik; Jan Wenzel; Ines Stölting; Lukas Huber; Olga Will; Eva Peschke; Urte Matschl; Jan-Bernd Hövener; Markus Schwaninger; Diana Jurk; Walter Raasch
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.